Results 151 to 160 of about 12,151 (255)
ABSTRACT Objectives Recent clinical studies have suggested that glucagon‐like peptide‐1 receptor (GLP‐1R) agonists may be effective therapies to treat or reduce the risk of developing secondary lymphedema. In this study, we aimed to (1) determine if GLP‐1Rs are present in the lymphatic vasculature and characterize their expression, and (2) assess the ...
Mary E. Schulz +3 more
wiley +1 more source
Reported use of anti-asthmatic medication in doping control forms from 2015 to 2019 - mapping retrospective data. [PDF]
Kojen AJ +5 more
europepmc +1 more source
Objective: To investigate the role of cysteinyl leukotrienic (cysLT) antagonists on conjunctival nitric oxide (NO) release in experimental allergic conjunctivitis.
Papathanassiou, M. +2 more
core
Association between leukotriene receptor antagonists and neuropsychiatric disorders: a systematic review and meta-analysis. [PDF]
Xian J, Zhang S, Zhang Y, Li K, Zhang Q.
europepmc +1 more source
Treatments and Targets to Achieve Disease Control in Chronic Spontaneous Urticaria: Current and Emerging Therapeutic Options. [PDF]
Østergaard CES, Thomsen SF, Zhang DG.
europepmc +1 more source
Leukotriene-modifying agent chemoprophylaxis for severe influenza illness: a multi-approach study. [PDF]
Snyder BM +10 more
europepmc +1 more source
Deacetylase inhibitors CM‐444 and CM‐1758 enhance chemotherapy response in AML via ALOX5
British Journal of Haematology, Volume 209, Issue 1, Page 329-334, July 2026.
Naroa Gimenez‐Camino +7 more
wiley +1 more source
Leukotriene antagonists and symptom control in chronic persistent asthma.
Ruth H Green +3 more
core +1 more source
The effect of lipoxygenase inhibitors and leukotriene antagonists on anaphylaxis
S. Franchi-Micheli +3 more
core +1 more source

